Update date
31 Dec 2021
Shareable Research Card
BCPC - BALCHEM CORP Revenues
This metric view shows BCPC - BALCHEM CORP revenues history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: 2021
- Latest reported value
- $799,023,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Dec 2021
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: 2021.
- Latest reported value on this page: $799,023,000.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Revenues
Latest reported revenues: $799,023,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
2021
SEC-backed company facts were refreshed from filings filed on 31 Jul 2026.
Benchmark Context
How Revenues compares with peers
BALCHEM CORP is outside the visible top 120 companies for revenues in the current sample.
Compared with
Compared with 120 companies reporting revenues in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Revenues is up about 14% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2018 to 30 Jun 2026.
- Nearby companies in this sample: Apple Inc. and CARDINAL HEALTH INC.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Plain-English Guide
What Revenues means
Revenue is the sales a company reports from customers before most expenses are subtracted.
Why people care
People start here to understand business scale and whether demand is growing before they ask about margins or cash flow.
How to read it
Check the latest reported period first, then compare the same quarter or year against prior periods so seasonality does not distort the story.
Compare next
Compare revenue with gross profit, operating income, and operating cash flow to see whether sales are turning into healthy economics.
Revenue can jump because of acquisitions, pricing changes, or revenue-recognition rules, and reporting periods may differ across companies.
Open a live SEC-backed example
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
BALCHEM CORP: Revenues
Latest period: 2021. Period end: 31 Dec 2021. Units: USD. Frequency: annual and quarterly.
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Metric snapshot
- Latest value
- $799,023,000
- Coverage range
- 31 Mar 2016 - 31 Dec 2021
- Fact rows
- 14
What this metric tells you
- Shows reported revenues over 31 Mar 2016 - 31 Dec 2021.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 14 SEC fact rows for this metric and issuer.
How to read this chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use annual sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
- Use the TTM line to smooth quarter-to-quarter noise.
Official SEC source
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Revenues levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Which companies report the highest revenue?
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | Apple Inc. (aapl) | $265,595,000,000 | Year - 29 Sep 2018 | Open Apple Inc. Revenues |
| 2 | CARDINAL HEALTH INC (cah) | $254,248,000,000 | Year - 30 Jun 2026 | Open CARDINAL HEALTH INC Revenues |
| 3 | FORD MOTOR CO (f) | $184,992,000,000 | Year - 31 Dec 2024 | Open FORD MOTOR CO Revenues |
| 4 | JPMORGAN CHASE & CO (jpm) | $182,447,000,000 | Year - 31 Dec 2025 | Open JPMORGAN CHASE & CO Revenues |
| 5 | Walmart Inc. (wmt) | $177,751,000,000 | Quarter - 30 Apr 2026 | Open Walmart Inc. Revenues |
| 6 | Alibaba Group Holding Ltd (baba) | $148,401,000,000 | Year - 31 Mar 2026 | Open Alibaba Group Holding Ltd Revenues |
Metric Details
- Metric
- Revenues (Revenues)
- Frequency coverage
-
annual and quarterly
Comparability: Compare annual with annual and quarterly with quarterly
- Taxonomy
- us-gaap
- Units tracked
- USD
- History range
-
31 Mar 2016 - 31 Dec 2021
Freshness: From parsed SEC XBRL facts on this page
- Facts on this page
-
14
Source: SEC company facts API
- Metric definition
-
Amount of revenue recognized from goods sold services rendered insurance premiums other activities that constitute an earning process. Includes but is not limited to investment interest income before deduction of interest expense when recognized as a component of revenue sales trading gain (loss).
- SEC metric endpoint
- Open SEC company concept
Metric identity
Names, identifiers, and filing context for this profile.
1 identity field
Metric coverage
3 source fields
How to read it
1 detail
Source evidence
Original filing metadata and source links for verification.
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
BALCHEM CORP Annual Revenues (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2021 | $799,023,000 | +$95,379,000 | +14% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 24 Feb 2022 | 2021 | FY |
| 2020 | $703,644,000 | +$59,939,000 | +9.3% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 24 Feb 2022 | 2021 | FY |
| 2019 | $643,705,000 | +$26,000 | +0% | 01 Jan 2019 | 31 Dec 2019 | 10-K | 24 Feb 2022 | 2021 | FY |
| 2018 | $643,679,000 | +$48,889,000 | +8.2% | 01 Jan 2018 | 31 Dec 2018 | 10-K | 19 Feb 2021 | 2020 | FY |
| 2017 | $594,790,000 | +$41,586,000 | +7.5% | 01 Jan 2017 | 31 Dec 2017 | 10-K | 21 Feb 2020 | 2019 | FY |
| 2016 | $553,204,000 | 01 Jan 2016 | 31 Dec 2016 | 10-K | 28 Feb 2019 | 2018 | FY |
BALCHEM CORP Quarterly Revenues (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | $594,790,000 | $159,264,000 | +$18,504,000 | +13% | 01 Oct 2017 | 31 Dec 2017 | 10-K | 01 Mar 2018 | 2017 | FY |
| Q3 2017 | $576,286,000 | $150,716,000 | +$12,207,000 | +8.8% | 01 Jul 2017 | 30 Sep 2017 | 10-K | 01 Mar 2018 | 2017 | FY |
| Q2 2017 | $564,079,000 | $147,082,000 | +$8,288,000 | +6% | 01 Apr 2017 | 30 Jun 2017 | 10-K | 01 Mar 2018 | 2017 | FY |
| Q1 2017 | $555,791,000 | $137,728,000 | +$2,587,000 | +1.9% | 01 Jan 2017 | 31 Mar 2017 | 10-K | 01 Mar 2018 | 2017 | FY |
| Q4 2016 | $553,204,000 | $140,760,000 | 01 Oct 2016 | 31 Dec 2016 | 10-K | 01 Mar 2018 | 2017 | FY | ||
| Q3 2016 | $138,509,000 | 01 Jul 2016 | 30 Sep 2016 | 10-K | 01 Mar 2018 | 2017 | FY | |||
| Q2 2016 | $138,794,000 | 01 Apr 2016 | 30 Jun 2016 | 10-K | 01 Mar 2018 | 2017 | FY | |||
| Q1 2016 | $135,141,000 | 01 Jan 2016 | 31 Mar 2016 | 10-K | 01 Mar 2018 | 2017 | FY |
* marks a reported value that did not pass the local value check.